CPB1 and hepatocellular carcinoma: Importantly, the uptake of CPBscr-DL633-SA bioconjugate was not significantly different to that of control DL633-SA-Biot complex in both cell types (Figure 6C,D), confirming that the specific amino acid sequence of CPB was crucial in the hepatoma cell targeting.